These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1283503)

  • 1. Comparative study of prostatic carcinoma bone metastasis among Japanese in Japan and Japanese Americans and whites in Hawaii.
    Shiraishi T; Atsumi S; Yatani R
    Adv Exp Med Biol; 1992; 324():7-16. PubMed ID: 1283503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical-pathological comparison of clinical prostate cancer between Japanese Americans in Hawaii and Japanese living in Japan.
    Fukagai T; Shimada M; Yoshida H; Namiki T; Carlile RG
    Int J Androl; 2000; 23 Suppl 2():43-4. PubMed ID: 10849493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. International comparison on ras gene mutations in latent prostate carcinoma.
    Watanabe M; Shiraishi T; Yatani R; Nomura AM; Stemmermann GN
    Int J Cancer; 1994 Jul; 58(2):174-8. PubMed ID: 8026877
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The frequency of latent prostatic carcinoma in young males: the Japanese experience.
    Shiraishi T; Watanabe M; Matsuura H; Kusano I; Yatani R; Stemmermann GN
    In Vivo; 1994; 8(3):445-7. PubMed ID: 7803732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K-ras activation and ras p21 expression in latent prostatic carcinoma in Japanese men.
    Konishi N; Enomoto T; Buzard G; Ohshima M; Ward JM; Rice JM
    Cancer; 1992 May; 69(9):2293-9. PubMed ID: 1562975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Geographic pathology of latent prostatic carcinoma.
    Yatani R; Chigusa I; Akazaki K; Stemmermann GN; Welsh RA; Correa P
    Int J Cancer; 1982 Jun; 29(6):611-6. PubMed ID: 7107064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival differences among Asian subpopulations in the United States after prostate, colorectal, breast, and cervical carcinomas.
    Lin SS; Clarke CA; Prehn AW; Glaser SL; West DW; O'Malley CD
    Cancer; 2002 Feb; 94(4):1175-82. PubMed ID: 11920489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of new phenotypic markers in cholangiocarcinoma and putative precursor lesions.
    Roncalli M; Patriarca C; Gambacorta M; Viale G; Coggi G
    J Surg Oncol Suppl; 1993; 3():173-4. PubMed ID: 7684914
    [No Abstract]   [Full Text] [Related]  

  • 9. Lifestyle determinants of 5alpha-reductase metabolites in older African-American, white, and Asian-American men.
    Wu AH; Whittemore AS; Kolonel LN; Stanczyk FZ; John EM; Gallagher RP; West DW
    Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):533-8. PubMed ID: 11352865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of ras activation in prostate carcinoma in Japanese and American men.
    Konishi N; Hiasa Y; Tsuzuki T; Tao M; Enomoto T; Miller GJ
    Prostate; 1997 Jan; 30(1):53-7. PubMed ID: 9018336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethnic difference in liver fat content: a cross-sectional observation among Japanese American in Hawaii, Japanese in Japan, and non-Hispanic whites in United States.
    Azuma K; Curb JD; Kadowaki T; Edmundowicz D; Kadowaki S; Masaki KH; El-Saed A; Nishio Y; Seto TB; Okamura T; Cetinel C; Kadota A; Sutton-Tyrrell K; Miura K; Evans RW; Takamiya T; Maegawa H; Miljkovic I; Kuller LH; Ueshima H; Kelley DE; Sekikawa A
    Obes Res Clin Pract; 2013; 7(3):e198-205. PubMed ID: 23697588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneous subpopulations of human prostatic adenocarcinoma cells: potential usefulness of P21 protein as a predictor for bone metastasis.
    Fan K
    J Urol; 1988 Feb; 139(2):318-22. PubMed ID: 2448499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Racial disparity in clinical course and outcome of metastatic androgen-independent prostate cancer.
    Thatai LC; Banerjee M; Lai Z; Vaishampayan U
    Urology; 2004 Oct; 64(4):738-43. PubMed ID: 15491712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation and proliferative activity in benign and malignant cartilage tumors of bone.
    Hasegawa T; Seki K; Yang P; Hirose T; Hizawa K; Wada T; Wakabayashi J
    Hum Pathol; 1995 Aug; 26(8):838-45. PubMed ID: 7543439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of ras oncogene p21 in prostate cancer.
    Viola MV; Fromowitz F; Oravez S; Deb S; Finkel G; Lundy J; Hand P; Thor A; Schlom J
    N Engl J Med; 1986 Jan; 314(3):133-7. PubMed ID: 2417118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential fibrotic stromal responses of host tissue to low- and high-metastatic cloned Lewis lung carcinoma cells.
    Nakanishi H; Oguri K; Takenaga K; Hosoda S; Okayama M
    Lab Invest; 1994 Mar; 70(3):324-32. PubMed ID: 7511714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral metastases as first symptom of cancer: a clinico-pathologic study.
    Giordana MT; Cordera S; Boghi A
    J Neurooncol; 2000 Dec; 50(3):265-73. PubMed ID: 11263507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tenascin in breast cancer development--is epithelial tenascin a marker for poor prognosis?
    Yoshida T; Ishihara A; Hirokawa Y; Kusakabe M; Sakakura T
    Cancer Lett; 1995 Mar; 90(1):65-73. PubMed ID: 7536626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced tenascin expression in colonic carcinoma with lymphogenous metastasis.
    Sugawara I; Hirakoshi J; Masunaga A; Itoyama S; Sakakura T
    Invasion Metastasis; 1991; 11(6):325-31. PubMed ID: 1726610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stage at diagnosis and survival in a multiethnic cohort of prostate cancer patients.
    Oakley-Girvan I; Kolonel LN; Gallagher RP; Wu AH; Felberg A; Whittemore AS
    Am J Public Health; 2003 Oct; 93(10):1753-9. PubMed ID: 14534233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.